Shijiazhuang Yiling Pharmaceutical Co., Ltd., a national key high-tech enterprise, was founded by Academician Wu Yiling of the Chinese Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the scientific and technological innovation development strategy of taking technology as the guide and market as the leader. The five-in-one unique operating model of "theory-clinical-scientific research-industry-teaching" establishes a new drug R & D and innovation technology system guided by theoretical innovation of traditional Chinese medicine collateral disease. The leaders of the Ministry of Science and Technology once praised the development model of the Trinity as "a pioneering work on the industrialization of scientific and technological achievements in Chinese medicine".
Yiling Pharmaceutical Industry promotes the industrialization of traditional Chinese medicine with innovations in the theory of collateral disease. It uses modern high-tech to develop scientific and technological Chinese medicine, western medicine and biological medicine. It has developed more than 10 national patent Chinese medicines, 13 clinical approvals, more than 20 preclinical medicines, and in-hospital preparations Hundreds, covering major diseases such as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors, and diabetes. The Chinese medicine production line certified by the national GMP and the chemical preparation production workshop certified by the European Union ensure the high quality of the product. Yiling Pharmaceutical is a national innovative enterprise and one of the top 50 listed pharmaceutical companies in China.
Yiling Pharmaceutical Industry promotes the industrialization of traditional Chinese medicine with innovations in the theory of collateral disease. It uses modern high-tech to develop scientific and technological Chinese medicine, western medicine and biological medicine. It has developed more than 10 national patent Chinese medicines, 13 clinical approvals, more than 20 preclinical medicines, and in-hospital preparations Hundreds, covering major diseases such as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors, and diabetes. The Chinese medicine production line certified by the national GMP and the chemical preparation production workshop certified by the European Union ensure the high quality of the product. Yiling Pharmaceutical is a national innovative enterprise and one of the top 50 listed pharmaceutical companies in China.
Following the discipline of traditional Chinese medicine "based on clinical practice, guided by theoretical hypotheses, based on treatment prescriptions, and based on clinical efficacy as the standard," the use of modern high-tech to promote the development of new clinical efficacy drugs based on theoretical originality. An innovative development model of "theory-clinical-research-industry-teaching" was formed.
